Skip to main content

OLAPARIB 50 mg Logo Pill - white capsule/oblong

Generic Name: olaparib

Pill with imprint OLAPARIB 50 mg Logo is White, Capsule/Oblong and has been identified as Lynparza 50 mg. It is supplied by AstraZeneca Pharmaceuticals LP.

Lynparza is used in the treatment of Ovarian Cancer; Prostate Cancer; Breast Cancer; Breast Cancer, Metastatic; Pancreatic Cancer and belongs to the drug class PARP inhibitors. There is positive evidence of human fetal risk during pregnancy. Lynparza 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for OLAPARIB 50 mg Logo

Lynparza 50 mg OLAPARIB 50 mg Logo
Lynparza 50 mg OLAPARIB 50 mg Logo
Lynparza 50 mg OLAPARIB 50 mg Logo


Generic Name
OLAPARIB 50 mg Logo
50 mg
Prescription only
Drug Class
PARP inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
AstraZeneca Pharmaceuticals LP
National Drug Code (NDC)
00310-0657 (Discontinued)
Inactive Ingredients
hypromelloses, titanium dioxide, shellac, ferrosoferric oxide, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.